6533b7d3fe1ef96bd125fdc2
RESEARCH PRODUCT
Evaluation of two treatment-modalities with ranibizumab for exudative age-related macular degeneration: inject and extend vs PRN (pro-re-nata)
Brice DugasDenis DossarpsYann KauffmannAlain BronCatherine Creuzot Garchersubject
[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologygenetic structures[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutrition[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organsdmladégénérescence rétinienne[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyeye diseasesdescription
Evaluation of two treatment-modalities with ranibizumab for exudative age-related macular degeneration: inject and extend vs PRN (pro-re-nata). annual meeting of the association-for-research-in-vision-and-ophthalmology (ARVO)
year | journal | country | edition | language |
---|---|---|---|---|
2011-04-22 |